Clinical Trial Update: Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/2 trial evaluating neoadjuvant short-course IMRT followed by surgery and intraoperative radiotherapy for resectable pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: University Hospital Heidelberg | Conditions: Pancreatic Neoplasms | Phase 1, Phase 2 | Status: UNKNOWN